Ingénierie Moléculaire, Cellulaire et Physiopathologie
Impact in
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms
-
- RNA modifications and cancer
- RNA and protein synthesis mechanisms
- RNA Research and Splicing
Papers in
- Rheumatology 223
- Osteoarthritis Treatment and Mechanisms 139
-
- RNA modifications and cancer 179
- RNA and protein synthesis mechanisms 149
- RNA Research and Splicing 103
- Top scholars
- Yuri MotorinMark HelmPatrick NetterJacques MagdalouGuy BranlantDidier MainardKira J. WeissmanVirginie Marchand
- Journals
- Bio-Medical Materials and Engineering (57 papers)Nucleic Acids Research (46 papers)Journal of Biological Chemistry (37 papers)Osteoarthritis and Cartilage (28 papers)Nature Communications (23 papers)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
Ingénierie Moléculaire, Cellulaire et Physiopathologie
1.4k papers receiving 39.1k citations
Peers
Comparison fields: 5 of 209
- Rheumatology 5.8k
- Molecular Biology 18.4k
- Cancer Research 3.6k
- Nephrology 1.8k
- Biomaterials 2.6k
Countries citing scholars working at Ingénierie Moléculaire, Cellulaire et Physiopathologie
This map shows the geographic impact of research produced by authors working at Ingénierie Moléculaire, Cellulaire et Physiopathologie. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Ingénierie Moléculaire, Cellulaire et Physiopathologie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingénierie Moléculaire, Cellulaire et Physiopathologie more than expected).
Fields of papers published by authors at Ingénierie Moléculaire, Cellulaire et Physiopathologie
This network shows the impact of papers affiliated with Ingénierie Moléculaire, Cellulaire et Physiopathologie at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Ingénierie Moléculaire, Cellulaire et Physiopathologie at the time of their publication.
About Ingénierie Moléculaire, Cellulaire et Physiopathologie
In recent decades, authors affiliated with Ingénierie Moléculaire, Cellulaire et Physiopathologie have published 1.5k papers, which have received a total of 43.6k indexed citations . Scholars at this organization have produced 223 papers in Rheumatology, 570 papers in Molecular Biology, 82 papers in Genetics, 98 papers in Cancer Research and 95 papers in Biomaterials on the topics of RNA modifications and cancer (179 papers), RNA and protein synthesis mechanisms (149 papers), Osteoarthritis Treatment and Mechanisms (139 papers), RNA Research and Splicing (103 papers), Proteoglycans and glycosaminoglycans research (63 papers), Mesenchymal stem cell research (59 papers), Cancer-related molecular mechanisms research (58 papers) and Immune Cell Function and Interaction (53 papers). Their work is cited by papers focused on Rheumatology (5.8k citations), Molecular Biology (18.4k citations), Cancer Research (3.6k citations), Nephrology (1.8k citations) and Biomaterials (2.6k citations). Authors at Ingénierie Moléculaire, Cellulaire et Physiopathologie collaborate with scholars in France, Germany and United States and have published in prestigious journals including Bio-Medical Materials and Engineering, Nucleic Acids Research, Journal of Biological Chemistry, Osteoarthritis and Cartilage and Nature Communications. Some of Ingénierie Moléculaire, Cellulaire et Physiopathologie's most productive authors include Yuri Motorin, Mark Helm, Patrick Netter, Jacques Magdalou, Guy Branlant, Didier Mainard, Kira J. Weissman, Virginie Marchand, Sandrine Boschi‐Müller and Christiane Branlant.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.